Efficacy & Safety of Olvi-Vec and Platinum-doublet + Bevacizumab Compared to Physician's Choice of Chemotherapy and Bevacizumab in Platinum-Resistant/Refractory Ovarian Cancer (PRROC) (OnPrime, GOG-3076)
Genelux Corporation
Genelux Corporation
Merck Sharp & Dohme LLC
Bristol-Myers Squibb
Merck Sharp & Dohme LLC
Merck Sharp & Dohme LLC
Merck Sharp & Dohme LLC
Jiangsu Hansoh Pharmaceutical Co., Ltd.
Eli Lilly and Company
Merck Sharp & Dohme LLC
Azaya Therapeutics, Inc.
Sanofi
Sanofi
Sanofi
Sanofi